Annika Muskantor

Annika Muskantor

No open positions remaining
60 year
Health Technology
Consumer Services
Technology Services

Profile

Annika Muskantor served as the Chief Financial Officer at Oncopeptides AB from 2021 to 2023.
Prior to that, she worked as the Interim Chief Financial Officer at Dun & Bradstreet AB. In 2012 to 2013, she held the position of Chief Financial Officer at Swedish Orphan Biovitrum AB. From 2019 to 2021, she served as the Chief Financial Officer at FRISQ Holding AB. Ms. Muskantor also worked as an Interim Chief Financial Officer at Zodiak Media AB, eBay Sweden Services AB, and Scienta Omicron AB. She was the Chief Financial Officer at Ganni A. Currently, she is the Chief Financial Officer at Net Insight AB. Ms. Muskantor completed her undergraduate studies at Northwestern University and holds an MBA from Kellogg School of Management.

Former positions of Annika Muskantor

CompaniesPositionEnd
NET INSIGHT AB Director of Finance/CFO 13/08/2024
ONCOPEPTIDES AB Director of Finance/CFO 17/01/2023
Director of Finance/CFO 30/03/2021
SWEDISH ORPHAN BIOVITRUM AB Director of Finance/CFO 07/04/2013
Director of Finance/CFO -
See the detail of Annika Muskantor's experience

Training of Annika Muskantor

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

22

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Electronic Technology

Consumer Services

Health Technology

Technology Services

Health Technology

Consumer Non-Durables

Consumer Services

Technology Services

Consumer Services

Technology Services

Health Technology

  1. Stock Market
  2. Insiders
  3. Annika Muskantor